Chang Su Kim

Dr. Chang Su Kim


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
APAyusha Pandey
Ayusha Pandey
DPDasol Park
Dasol Park
WHWONBAE HA
WONBAE HA
CKChang Su Kim
Chang Su Kim
ELEun Suk Lee
Eun Suk Lee
KKKang-Beom Kwon
Kang-Beom Kwon
Background/Objectives: Subjective memory complaints (SMCs) represent an early window for cognitive intervention; however, no approved pharmacological treatment exists at this stage. Gastrodia elata is a traditional medicinal plant, and preclinical studies suggest that it may influence synaptic plasticity, neurotrophic signaling, and neuroinflammatory pathways involved in memory; however, human evidence remains limited. Methods: This study was a randomized, participant- and assessor-blinded, placebo-controlled clinical trial in which the Clinical Research Coordinator, statistician, physician, and participants remained unaware of group assignment throughout the study period. Eighty adults with normal objective cognitive function and subjective memory complaints were randomized; 76 participants were included in the full analysis set (36 G. elata, 40 placebo) and all 80 in the safety set. Results: The prespecified primary outcome showed a small between-group difference in MoCA-K total score change: G. elata 0.72 ± 1.34 vs. placebo 0.13 ± 1.07 (between-group p = 0.034). Exploratory secondary analyses showed significant differences in MoCA-K delayed recall, K-MMSE total, K-MMSE memory recall and BDNF, whereas Digit Span and IL-6 did not differ significantly between groups. No serious adverse events occurred. The trial was retrospectively registered in CRIS (KCT0011966) on 12 May 2026. Conclusions: These findings provide preliminary evidence that G. elata supplementation may support selected cognitive outcomes in adults with SMCs, although the clinical relevance requires confirmation in larger, prospectively registered trials. Further studies incorporating neuroimaging and prespecified biomarker analyses are warranted to determine whether the observed cognitive findings are accompanied by objective changes in brain function or circulating biomarkers.

25 August 2026 in Foods
Verified
Journal Article
Open access
PDF file
HCHyun Jin Choi
Hyun Jin Choi
YKYe Seul Kwon
Ye Seul Kwon
YKYoung-Hoi Kim
Young-Hoi Kim
YGYoseph Asmelash Gebru
Yoseph Asmelash Gebru
ELEun Suk Lee
Eun Suk Lee
HCHan-Seok Choi
Han-Seok Choi
Gastrodia elata rhizome (GER), long used medicinally and as food in East Asia, is now produced via outdoor field (OFC) or indoor facility (IFC) cultivation. This study evaluated phenolic composition and antioxidant properties of GER by cultivation method, growth stage, and harvest season. Seven compounds were quantified by HPLC; parishin A, parishin B, parishin E, and p-hydroxybenzyl methyl ether (p-HBME) were the major constituents. Among mature samples, their total content ranged from 13.21 to 18.33 mg/g DW in OFC-grown GER and was 12.15 mg/g DW in IFC-grown GER, while immature GER contained up to 26.16 mg/g DW. However, IFC and OFC samples originated from different regions, so differences cannot be attributed solely to cultivation method. Spring-harvested GER had a higher total content of the seven compounds than autumn-harvested GER (20.67 ± 0.17 and 12.01 ± 0.19 mg/g DW, respectively) and stronger DPPH, FRAP, and ABTS activities, whereas total phenolic content (TPC) was higher in autumn. Seasonal comparisons reflect extraction replicates of composite samples, not independent biological replicates. ABTS activity was positively correlated with gastrodin, 4-hydroxybenzyl alcohol (4-HBA), p-HBME, parishin A, and total flavonoid content (TFC). PCA explained 71.5% of total variance (PC1–PC2), supporting discrimination among GER samples by phenolic and antioxidant profiles.